Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 26 16
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 31 11
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
hrsACE2 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021 2 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Fluvoxamine Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/27/2021 2 0
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Acarbose Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/12/2020 3 0
Hyaluronic acid Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/12/2020 2 0